Laboratory Medicine ›› 2025, Vol. 40 ›› Issue (9): 914-917.DOI: 10.3969/j.issn.1673-8640.2025.09.015
Previous Articles Next Articles
Received:
2024-07-28
Revised:
2025-06-19
Online:
2025-09-30
Published:
2025-09-30
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2025.09.015
项目 | 阴性/(个·μL-1) | 阳性/(个·μL-1) |
---|---|---|
红细胞 | ≤20 | >20 |
白细胞 | ≤20 | >20 |
管型 | ≤1 | >1 |
细菌 | ≤1 200 | >1 200 |
项目 | 阴性/(个·μL-1) | 阳性/(个·μL-1) |
---|---|---|
红细胞 | ≤20 | >20 |
白细胞 | ≤20 | >20 |
管型 | ≤1 | >1 |
细菌 | ≤1 200 | >1 200 |
项目 | 阴性 | 阳性 |
---|---|---|
隐血 | “-”“±” | “1+”“2+”“3+” |
白细胞酯酶 | “-” | “1+”“2+”“3+” |
蛋白 | “-”“±” | “1+”“2+”“3+”“4+” |
亚硝酸盐 | “-” | “+” |
项目 | 阴性 | 阳性 |
---|---|---|
隐血 | “-”“±” | “1+”“2+”“3+” |
白细胞酯酶 | “-” | “1+”“2+”“3+” |
蛋白 | “-”“±” | “1+”“2+”“3+”“4+” |
亚硝酸盐 | “-” | “+” |
项目 | 特异性/% | 敏感性/% | 阳性预测值/% | 阴性预测值/% | 假阳性率/% | 假阴性率/% | 准确率/% | Kappa值 |
---|---|---|---|---|---|---|---|---|
胆红素-红细胞 | 97.05 | 88.96 | 89.13 | 97.00 | 2.95 | 11.04 | 95.32 | 0.86 |
酯酶-白细胞 | 98.66 | 74.64 | 94.52 | 92.61 | 1.34 | 25.36 | 92.96 | 0.79 |
蛋白-管型 | 90.44 | 51.68 | 24.05 | 96.97 | 9.56 | 48.32 | 88.29 | 0.27 |
细菌-镜检细菌 | 99.80 | 64.48 | 97.35 | 96.18 | 0.20 | 35.52 | 96.26 | 0.76 |
项目 | 特异性/% | 敏感性/% | 阳性预测值/% | 阴性预测值/% | 假阳性率/% | 假阴性率/% | 准确率/% | Kappa值 |
---|---|---|---|---|---|---|---|---|
胆红素-红细胞 | 97.05 | 88.96 | 89.13 | 97.00 | 2.95 | 11.04 | 95.32 | 0.86 |
酯酶-白细胞 | 98.66 | 74.64 | 94.52 | 92.61 | 1.34 | 25.36 | 92.96 | 0.79 |
蛋白-管型 | 90.44 | 51.68 | 24.05 | 96.97 | 9.56 | 48.32 | 88.29 | 0.27 |
细菌-镜检细菌 | 99.80 | 64.48 | 97.35 | 96.18 | 0.20 | 35.52 | 96.26 | 0.76 |
项目 | 特异性/% | 敏感性/% | 阳性预测值/% | 阴性预测值/% | 假阳性率/% | 假阴性率/% | 准确率/% | Kappa值 |
---|---|---|---|---|---|---|---|---|
红细胞比对 | 94.44 | 96.81 | 82.56 | 99.09 | 5.56 | 3.19 | 94.95 | 0.86 |
白细胞比对 | 96.08 | 97.81 | 88.56 | 99.30 | 3.92 | 2.19 | 96.49 | 0.91 |
管型比对 | 99.05 | 91.84 | 84.99 | 99.52 | 0.95 | 8.16 | 98.65 | 0.88 |
细菌比对 | 99.35 | 98.34 | 94.42 | 99.81 | 0.65 | 1.66 | 99.25 | 0.96 |
项目 | 特异性/% | 敏感性/% | 阳性预测值/% | 阴性预测值/% | 假阳性率/% | 假阴性率/% | 准确率/% | Kappa值 |
---|---|---|---|---|---|---|---|---|
红细胞比对 | 94.44 | 96.81 | 82.56 | 99.09 | 5.56 | 3.19 | 94.95 | 0.86 |
白细胞比对 | 96.08 | 97.81 | 88.56 | 99.30 | 3.92 | 2.19 | 96.49 | 0.91 |
管型比对 | 99.05 | 91.84 | 84.99 | 99.52 | 0.95 | 8.16 | 98.65 | 0.88 |
细菌比对 | 99.35 | 98.34 | 94.42 | 99.81 | 0.65 | 1.66 | 99.25 | 0.96 |
组别 | 特异性 | 敏感性 | 阳性预测值 | 阴性预测值 | 假阳性率 | |||||
---|---|---|---|---|---|---|---|---|---|---|
UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | |
建立组 | 72.0 | 44.2 | 66.1 | 83.0 | 40.4 | 30.0 | 88.1 | 90.0 | 28.0 | 55.8 |
验证组 | 72.8 | 45.8 | 64.5 | 82.8 | 40.1 | 30.1 | 87.9 | 90.5 | 27.2 | 54.2 |
组别 | 假阴性率 | 拦截率 | 放行率 | 准确率 | ||||||
UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | |||
建立组 | 33.9 | 17.0 | 36.5 | 61.8 | 63.5 | 38.2 | 70.7 | 52.9 | ||
验证组 | 35.5 | 17.2 | 35.4 | 60.5 | 64.6 | 39.5 | 71.0 | 53.9 |
组别 | 特异性 | 敏感性 | 阳性预测值 | 阴性预测值 | 假阳性率 | |||||
---|---|---|---|---|---|---|---|---|---|---|
UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | |
建立组 | 72.0 | 44.2 | 66.1 | 83.0 | 40.4 | 30.0 | 88.1 | 90.0 | 28.0 | 55.8 |
验证组 | 72.8 | 45.8 | 64.5 | 82.8 | 40.1 | 30.1 | 87.9 | 90.5 | 27.2 | 54.2 |
组别 | 假阴性率 | 拦截率 | 放行率 | 准确率 | ||||||
UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | UC4N规则/% | UCallN规则/% | |||
建立组 | 33.9 | 17.0 | 36.5 | 61.8 | 63.5 | 38.2 | 70.7 | 52.9 | ||
验证组 | 35.5 | 17.2 | 35.4 | 60.5 | 64.6 | 39.5 | 71.0 | 53.9 |
组别 | 特异性/% | 敏感性/% | 阳性预测值/% | 阴性预测值/% | 假阳性率/% | 假阴性率/% | 拦截率/% | 放行率/% | 准确率/% |
---|---|---|---|---|---|---|---|---|---|
建立组 | 61.9 | 95.6 | 22.5 | 99.2 | 38.1 | 4.4 | 44.0 | 56.0 | 65.4 |
验证组 | 62.1 | 96.7 | 22.4 | 99.4 | 37.9 | 3.3 | 43.9 | 56.1 | 65.6 |
组别 | 特异性/% | 敏感性/% | 阳性预测值/% | 阴性预测值/% | 假阳性率/% | 假阴性率/% | 拦截率/% | 放行率/% | 准确率/% |
---|---|---|---|---|---|---|---|---|---|
建立组 | 61.9 | 95.6 | 22.5 | 99.2 | 38.1 | 4.4 | 44.0 | 56.0 | 65.4 |
验证组 | 62.1 | 96.7 | 22.4 | 99.4 | 37.9 | 3.3 | 43.9 | 56.1 | 65.6 |
规则序号 | 规则明细 | 规则解释 |
---|---|---|
规则1 | “RBC=阴性 and BLD=阳性” | UF-5000红细胞和UC-3500胆红素阴性、阳性判断不一致,需确认 |
规则2 | “RBC=阳性 and BLD=阴性” | UF-5000红细胞和UC-3500胆红素阴性、阳性判断不一致,需确认 |
规则3 | “WBC=阴性 and LEU=阳性” | UF-5000白细胞和UC-3500白细胞酯酶阴性、阳性判断不一致,需确认 |
规则4 | “WBC=阳性 and LEU=阴性” | UF-5000白细胞和UC-3500白细胞酯酶阴性、阳性判断不一致,需确认 |
规则5 | “CAST=阴性 and PRO=阳性” | UF-5000管型和UC-3500尿蛋白阴性、阳性判断不一致,需确认 |
规则6 | “CAST=阳性 and PRO=阴性” | UF-5000管型和UC-3500尿蛋白阴性、阳性判断不一致,需确认 |
规则7 | “BACT=阴性 and NIT=阳性” | UF-5000细菌和UC-3500细菌阴性、阳性判断不一致,需确认 |
规则8 | “BACT=阳性 and NIT=阴性” | UF-5000细菌和UC-3500细菌阴性、阳性判断不一致,需确认 |
规则9 | “UF的RBC或WBC或CAST或BACT结果为‘——’” | 可能检测项目结果超出线性或遇到干扰,需确认 |
规则10 | “ATYP.C>0.1个/μL” | 可能存在异常细胞,需确认 |
规则11 | “PH>8 and SPERM=‘+’” | 蛋白可能为假阳性,需确认 |
规则12 | “PATH.CAST>1个/μL” | 可能存在病理管型,需确认 |
规则13 | “NON SEC>20个/μL” | 可能存在肾小管上皮细胞,需确认 |
规则14 | “RBC/YLC?” | 可能存在红细胞假阳性,需确认 |
规则15 | “Abnormal urine conductivity” | 电导率异常可能导致红细胞假阴性,需确认 |
规则16 | “RBC Carry over?” | 红细胞高值样本携带污染,需确认 |
规则17 | “WBC Carry over?” | 白细胞高值样本携带污染,需确认 |
规则18 | “BACT Carry over?” | 细菌高值样本携带污染,需确认 |
规则序号 | 规则明细 | 规则解释 |
---|---|---|
规则1 | “RBC=阴性 and BLD=阳性” | UF-5000红细胞和UC-3500胆红素阴性、阳性判断不一致,需确认 |
规则2 | “RBC=阳性 and BLD=阴性” | UF-5000红细胞和UC-3500胆红素阴性、阳性判断不一致,需确认 |
规则3 | “WBC=阴性 and LEU=阳性” | UF-5000白细胞和UC-3500白细胞酯酶阴性、阳性判断不一致,需确认 |
规则4 | “WBC=阳性 and LEU=阴性” | UF-5000白细胞和UC-3500白细胞酯酶阴性、阳性判断不一致,需确认 |
规则5 | “CAST=阴性 and PRO=阳性” | UF-5000管型和UC-3500尿蛋白阴性、阳性判断不一致,需确认 |
规则6 | “CAST=阳性 and PRO=阴性” | UF-5000管型和UC-3500尿蛋白阴性、阳性判断不一致,需确认 |
规则7 | “BACT=阴性 and NIT=阳性” | UF-5000细菌和UC-3500细菌阴性、阳性判断不一致,需确认 |
规则8 | “BACT=阳性 and NIT=阴性” | UF-5000细菌和UC-3500细菌阴性、阳性判断不一致,需确认 |
规则9 | “UF的RBC或WBC或CAST或BACT结果为‘——’” | 可能检测项目结果超出线性或遇到干扰,需确认 |
规则10 | “ATYP.C>0.1个/μL” | 可能存在异常细胞,需确认 |
规则11 | “PH>8 and SPERM=‘+’” | 蛋白可能为假阳性,需确认 |
规则12 | “PATH.CAST>1个/μL” | 可能存在病理管型,需确认 |
规则13 | “NON SEC>20个/μL” | 可能存在肾小管上皮细胞,需确认 |
规则14 | “RBC/YLC?” | 可能存在红细胞假阳性,需确认 |
规则15 | “Abnormal urine conductivity” | 电导率异常可能导致红细胞假阴性,需确认 |
规则16 | “RBC Carry over?” | 红细胞高值样本携带污染,需确认 |
规则17 | “WBC Carry over?” | 白细胞高值样本携带污染,需确认 |
规则18 | “BACT Carry over?” | 细菌高值样本携带污染,需确认 |
组别 | 特异性 | 敏感性 | 阳性预测值 | 阴性预测值 | 假阳性率 | |||||
---|---|---|---|---|---|---|---|---|---|---|
UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | |
建立组 | 58.5 | 82.9 | 99.5 | 95.6 | 21.7 | 39.3 | 99.9 | 99.4 | 41.5 | 17.1 |
验证组 | 59.2 | 82.8 | 99.7 | 96.9 | 21.6 | 38.9 | 99.9 | 99.6 | 40.8 | 17.2 |
组别 | 假阴性率 | 拦截率 | 放行率 | 准确率 | ||||||
UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | |||
建立组 | 0.5 | 4.4 | 47.5 | 25.2 | 52.5 | 74.8 | 62.8 | 84.3 | ||
验证组 | 0.3 | 3.1 | 46.8 | 25.3 | 53.2 | 74.7 | 63.3 | 84.3 |
组别 | 特异性 | 敏感性 | 阳性预测值 | 阴性预测值 | 假阳性率 | |||||
---|---|---|---|---|---|---|---|---|---|---|
UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | |
建立组 | 58.5 | 82.9 | 99.5 | 95.6 | 21.7 | 39.3 | 99.9 | 99.4 | 41.5 | 17.1 |
验证组 | 59.2 | 82.8 | 99.7 | 96.9 | 21.6 | 38.9 | 99.9 | 99.6 | 40.8 | 17.2 |
组别 | 假阴性率 | 拦截率 | 放行率 | 准确率 | ||||||
UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | UCUFallN规则/% | AUTOV规则/% | |||
建立组 | 0.5 | 4.4 | 47.5 | 25.2 | 52.5 | 74.8 | 62.8 | 84.3 | ||
验证组 | 0.3 | 3.1 | 46.8 | 25.3 | 53.2 | 74.7 | 63.3 | 84.3 |
[1] | 中国医师协会检验医师分会. 尿液常规检验诊断报告模式专家共识[J]. 中华医学杂志, 2017, 97(18):1369-1372. |
[2] | 尚红, 王毓三, 申子瑜. 全国临床检验操作规程[M]. 4版. 北京: 人民卫生出版社, 2015. |
[3] |
WANG L, GUO Y, HAN J, et al. Establishment of the intelligent verification criteria for a routine urinalysis analyzer in a multi-center study[J]. Clin Chem Lab Med, 2019, 57(12):1923-1932.
DOI PMID |
[4] | 中国合格评定国家认可委员会.CNAS-CL02-A001 医学实验室质量和能力认可准则的应用要求[S]. 北京: 中国合格评定国家认可委员会, 2023. |
[5] | 于海立, 王丹, 覃英, 等. SYSMEX尿干化学UC-3500与尿流式UF-4000在尿液检测中的应用评价[J]. 标记免疫分析与临床, 2022, 29(4):692-695. |
[6] | 孙金燕, 高志琪, 娄霞, 等. 尿液分析系统智能审核规则的建立与临床验证[J]. 标记免疫分析与临床, 2023, 30(9):1577-1583. |
[1] | LIU Shanfeng, GAO Yun, WANG Limin, WANG Ping. Accuracy analysis of urine protein and urine cast of hospitalized liver cirrhosis patients [J]. Laboratory Medicine, 2025, 40(3): 287-293. |
[2] | WANG Xiaomei, LUO Chao, TIE Yang, HE Yong, YANG Xikui, LIU Yalin, SUN Yue, WANG Fugang, HE He. Application of random urine uric acid/creatinine in classification of hyperuricemia patients in Karamay [J]. Laboratory Medicine, 2024, 39(9): 859-864. |
[3] | WANG Limin, LIU Shanfeng, WANG Ping. Positive rate of urine cast after heart transplantation and its influencing factors [J]. Laboratory Medicine, 2024, 39(9): 900-904. |
[4] | . [J]. Laboratory Medicine, 2024, 39(7): 721-722. |
[5] | . [J]. Laboratory Medicine, 2020, 35(1): 92-94. |
[6] | YU Peijuan, ZHANG Gaolin, YAN Ruhong, FENG Ping, SUN Lanyun, ZHU Xueming, WANG Jinghua. Urinary sediment analysis combined with serum procalcitonin determination in the diagnosis of urinary tract infection [J]. Laboratory Medicine, 2018, 33(4): 299-304. |
[7] | HUANG Yan, XU Xiaorong, ZHANG Jue. Performance evaluation of Cobio Palio 300 urine biochemical analyzer for the determinations of 5 urinary micro-proteins [J]. Laboratory Medicine, 2015, 30(6): 603-606. |
[8] | . [J]. , 2011, 26(06): 413-415. |
[9] | . [J]. , 2011, 26(03): 168-171. |
[10] | CHEN Guoqiang;CHEN Feng;WANG Sumei. The influence of urine specimen storage time on the determination results of RBC and WBC in urine [J]. , 2011, 26(03): 166-168. |
[11] | HANG Jianfeng;SUN Zhaohui;SHI Yuling;FU Yuwen;YANG Zhiyi;LUO Jian. Clinical application analysis on the performance of Sysmex UF-1000i automated urinary sediment analyzer [J]. , 2011, 26(02): 108-110. |
[12] | HU Xiaozhou;CUI Yanmei;WANG Xiaolin;ZHANG Jie. Comparison on three methods in the examination of urine sediment [J]. , 2011, 26(02): 100-104. |
[13] | . [J]. , 2010, 25(11): 909-913. |
[14] | DING Bangsheng;KONG Jianxin;MA Xiaoling;ZHU Xinyou. Comparison on the results of two urinary sediment automatic analyzers [J]. , 2010, 25(08): 615-617. |
[15] | . [J]. , 2009, 24(12): 918-920. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||